Rate of TP53 mutations in HPV-positive (HPV+) recurrent/metastatic head and neck cancer (RMHNC) patients.

被引：0
|
作者：
Thach, Dzung
Ahmad, Moin
Penta, Adrienne L.
Sulkowski, Gisela N.
Kallakury, Bhaskar
Chahine, Joeffrey J.
Niederhuber, John E.
Iyer, Ramaswamy K.
Deeken, John F.
机构：
[1] Inova Translat Med Inst, Falls Church, VA USA
[2] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[3] Inova Comprehens Canc & Res Inst, Mclean, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17094
引用
收藏
页数：1
相关论文
共 50 条
  • [41] mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
    Coppock Joseph D
    Lee John H
    世界耳鼻咽喉头颈外科杂志（英文）, 2016, 2 (02)
  • [42] Comparative responses of HPV-positive vs HPV-negative head and neck cancer cells to radiation and/or chemotherapeutic drugs
    Kimple, Randall J.
    Yang, Robert Z.
    Armstrong, Eric A.
    Lambert, Paul F.
    Harari, Paul M.
    CANCER RESEARCH, 2011, 71
  • [43] Apatinib in recurrent or metastatic head and neck cancer patients.
    Wu, Qiuji
    Liu, Jia
    Li, Shaojie
    Wang, Juan
    Zhong, Yahua
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18010 - E18010
  • [44] Pathogenic TP53 mutations influence chemotherapy response and survival rate of patients with HPV-negative oral carcinomas
    Jovic, Sasa
    Kozomara, Ruzica
    Stosic, Srboljub
    Jovandic, Stevo
    Zeljic, Katarina
    Supic, Gordana
    VOJNOSANITETSKI PREGLED, 2022, 79 (11) : 1063 - 1072
  • [45] Differences between HPV-positive and HPV-negative Head and Neck cancer patients as detected with FDG F18 PET/CT
    Ryan, Amy
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [46] Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
    Stoegbauer, Fabian
    Beck, Susanne
    Ourailidis, Iordanis
    Hess, Jochen
    Poremba, Christopher
    Lauterbach, Maren
    Wollenberg, Barbara
    Buchberger, Anna Maria Stefanie
    Jesinghaus, Moritz
    Schirmacher, Peter
    Stenzinger, Albrecht
    Weichert, Wilko
    Boxberg, Melanie
    Budczies, Jan
    BRITISH JOURNAL OF CANCER, 2023, 128 (12) : 2295 - 2306
  • [47] Association of head and neck cancer (HNSCC) subgroups defined by HPV RNA status, gene expression patterns, and TP53 mutations with lymph node metastasis and survival
    Dietz, Andreas
    Wichmann, Gunnar
    Rosolowski, Marciej
    Krohn, Knut
    Kreuz, Markus
    Boehm, Andreas
    Halama, Dirk
    Holzinger, Dana
    Pawlita, Michael
    Hess, Jochen
    Engel, Christoph
    Hasenclever, Dirk
    Scholz, Markus
    Ahnert, Peter
    Kirsten, Holger
    Hemprich, Alexander
    Wittekind, Christian
    Herbarth, Olf
    Loeffler, Markus
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells
    Scalia, Alessandro
    Kindt, Nadege
    Trelcat, Anne
    Nachtergael, Amandine
    Duez, Pierre
    Journe, Fabrice
    Carlier, Stephane
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [49] Differential expression of cancer stem cell markers in HPV-positive and HPV-negative squamous cell carcinoma of the head and neck
    Volavsek, M.
    Zidar, N.
    VIRCHOWS ARCHIV, 2014, 465 : S34 - S35
  • [50] The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer
    Wichmann, Gunnar
    Rosolowski, Maciej
    Krohn, Knut
    Kreuz, Markus
    Boehm, Andreas
    Reiche, Anett
    Scharrer, Ulrike
    Halama, Dirk
    Bertolini, Julia
    Bauer, Ulrike
    Holzinger, Dana
    Pawlita, Michael
    Hess, Jochen
    Engel, Christoph
    Hasenclever, Dirk
    Scholz, Markus
    Ahnert, Peter
    Kirsten, Holger
    Hemprich, Alexander
    Wittekind, Christian
    Herbarth, Olf
    Horn, Friedemann
    Dietz, Andreas
    Loeffler, Markus
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (12) : 2846 - 2857
12345